Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
BMC Gastroenterol ; 23(1): 239, 2023 Jul 15.
Article in English | MEDLINE | ID: mdl-37454061

ABSTRACT

BACKGROUND: Thiopurines continue to play an important role in the treatment of inflammatory bowel disease (IBD). It is well known that thiopurines can cause several adverse reactions. Especially, hematopoietic toxicity may lead to severe agranulocytosis. In a previous prospective study, we investigated the relationship between inosine triphosphate pyrophosphatase (ITPA) c.94c > a polymorphism, 6-thioguanine nucleotide (6-TGN) concentration and toxicity. METHODS: To clarify the cause of thiopurine toxicity, we analysed nucleoside disphosphate-linked moiety X-type motif 15 (NUDT15) gene polymorphisms, i.e., R139C, V18I, and V19_V19insGV, and measured 6-mercaptopurines and 6-methylmercaptopurines (6-MMP) using the archived blood samples collected from 49 IBD patients for our previous study. RESULTS: The ITPA c.94c > a polymorphism was detected in 19 patients (38.7%, all heterozygous). The R139C polymorphism was found in 10 patients (20.4%, 1 homozygous, 9 heterozygous), V18_V19insGV in 7 patients (14.3%, all heterozygous), and V18I in 2 patients (4.08%, all heterozygous). Although R139C was more strongly associated with leukopenia than c.94c > a, there were no significant correlations with 6-TGN and 6-MMP levels, as for c.94c > a. The leukopenia incidence rates for each gene polymorphism were 0% in those with all wild-type genes, 21.4% for c.94c > a only, 42.9% for NUDT15 polymorphism (s) only, and 80.0% for both polymorphisms. CONCLUSIONS: All cases of leukopenia were associated with ITPA c.94c > a and/or polymorphism of NUDT15 and the risk of developing leukopenia was synergistically increased by ITPA and NUDT15 gene polymorphism. However, there was no association between the level of azathioprine metabolites and these polymorphisms.


Subject(s)
Azathioprine , Inflammatory Bowel Diseases , Leukopenia , Pyrophosphatases , Humans , Azathioprine/adverse effects , Azathioprine/therapeutic use , East Asian People , Inflammatory Bowel Diseases/drug therapy , Inflammatory Bowel Diseases/genetics , Leukopenia/chemically induced , Leukopenia/genetics , Mercaptopurine/adverse effects , Pyrophosphatases/genetics
2.
PLoS One ; 15(11): e0241337, 2020.
Article in English | MEDLINE | ID: mdl-33151988

ABSTRACT

INTRODUCTION: Indigo naturalis (IN) is a blue pigment extracted from Assam indigo and other plants and has been confirmed to be highly effective for ulcerative colitis (UC) treatment in several clinical studies. OBJECTIVE: We conducted a multicenter double-blind study to confirm the efficacy and safety of short-term IN administration. METHODS: A multicenter, randomized controlled trial was conducted between December 2015 and October 2018 in our facilities. Forty-six patients with mild to moderate active UC (Lichtiger index: 5-10) were randomly assigned to the IN group or the placebo group and received 5 capsules (500 mg) twice a day for 2 weeks. We investigated the efficacy according to blood tests and the Lichtiger index before and after administration, and we also examined adverse events. RESULTS: The analysis included 42 patients (20 males, 22 females) with an average age of 45 years. Nineteen patients were assigned to the placebo group, and 23 were assigned to the IN group. After treatment administration, in the placebo group, no change in the Lichtiger index was observed (7.47 to 6.95, p = 0.359), and hemoglobin was significantly reduced (12.7 to 12.4, p = 0.031), while in the IN group, the Lichtiger index (9.04 to 4.48, p = 0.001) and albumin (4.0 to 4.12, p = 0.022) improved significantly. Mild headaches were observed in 5 patients and 1 patient in the IN and placebo groups, respectively. CONCLUSIONS: Short-term administration of IN is highly effective without serious adverse events such as pulmonary hypertension or intussusception and may prevent the occurrence of serious adverse events.


Subject(s)
Colitis, Ulcerative/drug therapy , Indigo Carmine/adverse effects , Indigo Carmine/therapeutic use , Adolescent , Adult , Aged , Double-Blind Method , Female , Humans , Male , Middle Aged , Surveys and Questionnaires , Time Factors , Treatment Outcome , Young Adult
3.
Drug Discov Ther ; 13(6): 354-359, 2019.
Article in English | MEDLINE | ID: mdl-31956234

ABSTRACT

Crohn's disease (CD) development is thought to involve genetic factors related to immune response as well as environmental factors, such as intestinal bacteria and diet, though no clear cause has yet been identified. In our previous study, we found that the concentrations of linoleic acid, stearic acid, and metabolites in erythrocytes differed between CD patients and healthy subjects. These factors related to lipid metabolism are controlled by Δ6 desaturase (fatty acid desaturase 2, FADS2) and elongase 6 (ELOVL6), respectively. In the present study, we analyzed the gene sequences of FADS2 and ELOVL6 in 52 Japanese CD patients, and then compared mutation frequencies with findings in healthy individuals. Nineteen FADS2 mutations and 33 ELOVL6 mutations were found. Furthermore, a new variant in the promoter region was shown in both genes, though no mutation in the coding region was found in either. For the FADS2 intron, the allele frequency of rs227784 (0.3365; 95% CI = 0.0337-0.01460) was higher than that in healthy subjects (0.0190). Furthermore, allele rs227784 had a greater association with CD (odds ratio = 4.4; 95% CI = 2.1-9.3). As compared with healthy Japanese healthy individuals, no mutations were found with a largely deviated allele frequency in the present CD group. However, the number of patients examined was small, thus the reliability of our results is limited. The present findings regarding genetic effects on CD onset and lipid metabolism may be weak.


Subject(s)
Crohn Disease/genetics , Fatty Acid Desaturases/genetics , Fatty Acid Elongases/genetics , Mutation Rate , Case-Control Studies , Female , Gene Frequency , Genetic Predisposition to Disease , Humans , Japan , Lipid Metabolism , Male
4.
Dig Dis ; 36(3): 209-217, 2018.
Article in English | MEDLINE | ID: mdl-29275413

ABSTRACT

BACKGROUND: We have previously reported that patients with Crohn's disease (CD) have a very specific erythrocyte membrane phospholipid fatty acid profile. The findings of this study suggest that the activities of enzymes involved in the metabolism of linoleic acid (LA), that is, delta-6 desaturase, are higher in CD patients than in healthy individuals. METHODS: We evaluated the utilities of various fatty acid compositions of the plasma (p-) as new serological markers for CD compared to those of erythrocyte membranes (e-). RESULTS: Fifty CD patients and 50 healthy individuals were enrolled. In both plasma and erythrocyte membranes, the weight percentages of palmitic acid (PA) were significantly higher, while those of LA were significantly lower in CD patients than in controls. Fatty acids with high sensitivity and specificity were p-PA (0.86 and 0.74) and e-PA (0.80 and 0.74). With PA and LA as a CD fatty acid index (CDFAi), that is, CDFAi = (PA/LA), the sensitivity and specificity of plasma CDFAi (p-CDFAi) and e-CDFAi were 0.80 and 0.80; and 0.82 and 0.88 respectively. CONCLUSION: In CD patients, various fatty acids were specifically altered in both plasma and erythrocytes, and p-PA and p-CDFAi are potentially useful as new serological markers for CD.


Subject(s)
Crohn Disease/blood , Fatty Acids/blood , Adult , Biomarkers/blood , Case-Control Studies , Erythrocyte Membrane/metabolism , Female , Humans , Male , Middle Aged , Phospholipids/blood , ROC Curve , Sensitivity and Specificity
5.
Nihon Shokakibyo Gakkai Zasshi ; 114(11): 1978-1986, 2017.
Article in Japanese | MEDLINE | ID: mdl-29109346

ABSTRACT

Metastasis of uveal melanoma of the digestive tract is rare. We report a case of a patient with metastatic uveal melanoma of the liver and digestive tract. A 68-year-old man was admitted with primary complaint of appetite loss and fatigue. Abdominal computed tomography revealed a 13-cm diameter tumor in the right lobe of the liver. We diagnosed him with metastatic uveal melanoma. We performed a liver tumor biopsy and diagnosed metastatic melanoma;we found distant metastases in the stomach, duodenum, and rectum on endoscopic biopsy. We administered systemic chemotherapy [DACa-Tam therapy (Dacarbazine, 220mg/m2×3 days;Nimustine, 60mg/m2×1 day;Carboplatin area under the curve (AUC) =4×1 day;Tamoxifen, 40mg/day×3 days)]. Prognosis is unfavorable in approximately half of the patients with liver metastases that occur through blood circulation. The patient died of liver failure two months after the diagnosis.


Subject(s)
Gastrointestinal Neoplasms/secondary , Liver Neoplasms/secondary , Melanoma/pathology , Uveal Neoplasms/pathology , Aged , Fatal Outcome , Gastrointestinal Neoplasms/diagnostic imaging , Humans , Liver Neoplasms/diagnostic imaging , Male
6.
World J Gastroenterol ; 22(17): 4275-86, 2016 May 07.
Article in English | MEDLINE | ID: mdl-27158196

ABSTRACT

Colorectal cancer (CRC) is one of the most common cancers and a leading cause of cancer-related mortality worldwide. Although systemic therapy is the standard care for patients with recurrent or metastatic CRC, the prognosis is extremely poor. The optimal sequence of therapy remains unknown. Therefore, alternative strategies, such as immunotherapy, are needed for patients with advanced CRC. This review summarizes evidence from dendritic cell-based cancer immunotherapy strategies that are currently in clinical trials. In addition, we discuss the possibility of antitumor immune responses through immunoinhibitory PD-1/PD-L1 pathway blockade in CRC patients.


Subject(s)
Colorectal Neoplasms/therapy , Dendritic Cells/immunology , Immunotherapy/methods , B7-H1 Antigen/antagonists & inhibitors , Carcinoembryonic Antigen/immunology , Colorectal Neoplasms/immunology , Humans , Melanoma-Specific Antigens/immunology , Programmed Cell Death 1 Receptor/antagonists & inhibitors , T-Lymphocytes, Cytotoxic/immunology , WT1 Proteins/immunology
7.
World J Gastroenterol ; 21(39): 11168-78, 2015 Oct 21.
Article in English | MEDLINE | ID: mdl-26494971

ABSTRACT

AIM: To investigate the association of plasma levels of interleukin (IL)-6 and -8 with Wilms' tumor 1 (WT1)-specific immune responses and clinical outcomes in patients with pancreatic ductal adenocarcinoma (PDA) treated with dendritic cells (DCs) pulsed with three types of major histocompatibility complex class I and II-restricted WT1 peptides combined with chemotherapy. METHODS: During the entire treatment period, plasma levels of IL-6 and -8 were analyzed by ELISA. The induction of WT1-specific immune responses was assessed using the WT1 peptide-specific delayed-type hypersensitivity (DTH) test. RESULTS: Three of 7 patients displayed strong WT1-DTH reactions throughout long-term vaccination with significantly decreased levels of IL-6/-8 after vaccinations compared with the levels prior to treatment. Moreover, overall survival (OS) was significantly longer in PDA patients with low plasma IL-6 levels (< 2 pg/mL) after 5 vaccinations than in patients with high plasma IL-6 levels (≥ 2 pg/mL) (P = 0.025). After disease progression, WT1-DTH reactions decreased severely and were ultimately negative at the terminal stage of cancer. The decreased levels of IL-6/-8 observed throughout long-term vaccination were associated with WT1-specific DTH reactions and long-term OS. CONCLUSION: Prolonged low levels of plasma IL-6/-8 in PDA patients may be a prognostic marker for the clinical outcomes of chemoimmunotherapy.


Subject(s)
Antimetabolites, Antineoplastic/administration & dosage , Biomarkers, Tumor/blood , Carcinoma, Pancreatic Ductal/drug therapy , Dendritic Cells/transplantation , Deoxycytidine/analogs & derivatives , Immunotherapy/methods , Interleukin-6/blood , Interleukin-8/blood , Pancreatic Neoplasms/drug therapy , Adult , Aged , Antimetabolites, Antineoplastic/adverse effects , Carcinoma, Pancreatic Ductal/blood , Carcinoma, Pancreatic Ductal/immunology , Carcinoma, Pancreatic Ductal/mortality , Carcinoma, Pancreatic Ductal/pathology , Cells, Cultured , Chemotherapy, Adjuvant , Dendritic Cells/immunology , Deoxycytidine/administration & dosage , Deoxycytidine/adverse effects , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunologic Tests , Immunotherapy/adverse effects , Kaplan-Meier Estimate , Male , Middle Aged , Pancreatic Neoplasms/blood , Pancreatic Neoplasms/immunology , Pancreatic Neoplasms/mortality , Pancreatic Neoplasms/pathology , Peptide Fragments/immunology , Time Factors , Tomography, X-Ray Computed , Treatment Outcome , WT1 Proteins/immunology , Gemcitabine
8.
PLoS One ; 10(9): e0137798, 2015.
Article in English | MEDLINE | ID: mdl-26360046

ABSTRACT

Azathioprine (AZA) is frequently used in patients with inflammatory bowel disease (IBD). However, toxic adverse reactions frequently develop and limit the clinical benefits. Currently, the precise mechanisms underlying thiopurine-related toxicity are not well understood. To investigate the relationship between the extent of thiopurine metabolism and adverse reactions in Japanese IBD patients, we prospectively observed 48 IBD patients who received AZA. We analyzed the thiopurine S-methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) gene mutations and measured the concentrations of 6-thioguanine nucleotide (6-TGN) continuously for 52 weeks. All patients possessed wild-type TPMT gene sequences. The ITPA 94C>A mutation was detected in 19 patients (39.6%). Adverse reactions developed in 14 of the 48 patients (29.2%), including leukopenia in 10 patients (20.8%). In the leukopenia group, the percentages of patients with 94C>A were higher than those in the without-leukopenia group (70.0% vs. 31.6%, P < 0.05). The average concentrations of 6-TGN in the patients with 94C>A were generally higher than those in the patients without 94C>A, however, there were no significant differences. Only 3 out of 10 patients with leukopenia exhibited high 6-TGN levels (30.0%). No negative correlations between white blood cell (WBC) counts and 6-TGN concentrations were observed. The cumulative incidence of leukopenia were higher for patients with 94C>A. Seven out of 19 patients (36.8%) with the ITPA 94C>A mutation developed leukopenia; however, this mutation may not unequivocally increase the risk of developing leukopenia. In addition, there are factors other than increased 6-TGN levels that are involved in the onset of leukopenia.


Subject(s)
Azathioprine/adverse effects , Azathioprine/metabolism , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/metabolism , Inflammatory Bowel Diseases/drug therapy , Inflammatory Bowel Diseases/metabolism , Adult , Alleles , Erythrocytes/metabolism , Female , Genotype , Guanine Nucleotides/metabolism , Humans , Incidence , Inflammatory Bowel Diseases/genetics , Japan , Leukopenia/epidemiology , Leukopenia/etiology , Male , Methyltransferases/genetics , Methyltransferases/metabolism , Middle Aged , Mutation , Pharmacogenetics , Prospective Studies , Pyrophosphatases/genetics , Pyrophosphatases/metabolism , Thionucleotides/metabolism , Young Adult
9.
Anticancer Res ; 35(1): 555-62, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25550602

ABSTRACT

BACKGROUND/AIM: Treatment combining dendritic cells (DCs) pulsed with three types of major histocompatibility complex (MHC) class I and II (DC/WT1-I/II)-restricted Wilms' tumor 1 (WT1) peptides with chemotherapy may stabilize disease in pancreatic cancer patients. MATERIALS AND METHODS: Laboratory data from seven patients with pancreatic cancer who underwent combined DC/WT1-I/II vaccination and chemotherapy were analyzed. The DC phenotypes and plasma cytokine profiles were analyzed via flow cytometry. RESULTS: The post-treatment neutrophil to lymphocyte (N/L) ratio was a treatment-related prognostic factor for better survival. Moreover, the mean fluorescence intensities (MFIs) of human leukocyte antigen (HLA)-DR and cluster of differentiation (CD)83 on DCs were significantly increased after chemoimmunotherapy. Interestingly, interleukin (IL)-6 level in plasma was significantly increased after chemoimmunotherapy in non-super-responders. CONCLUSION: An increased N/L ratio, as well as HLA-DR and CD83 MFI levels may be prognostic markers of longer survival in patients with advanced pancreatic cancer who undergo chemoimmunotherapy.


Subject(s)
Adenocarcinoma/therapy , Cancer Vaccines/immunology , Histocompatibility Antigens Class II/immunology , Histocompatibility Antigens Class I/immunology , Pancreatic Neoplasms/therapy , WT1 Proteins/immunology , Adenocarcinoma/immunology , Adenocarcinoma/mortality , Adenocarcinoma/secondary , Adult , Aged , Antimetabolites, Antineoplastic/therapeutic use , Biomarkers, Tumor , Cancer Vaccines/administration & dosage , Cells, Cultured , Combined Modality Therapy , Cytokines/blood , Dendritic Cells/immunology , Dendritic Cells/transplantation , Deoxycytidine/analogs & derivatives , Deoxycytidine/therapeutic use , Female , Humans , Lymphocyte Count , Male , Middle Aged , Neutrophils/immunology , Pancreatic Neoplasms/immunology , Pancreatic Neoplasms/mortality , Pancreatic Neoplasms/pathology , Peptide Fragments/immunology , Prognosis , Treatment Outcome , Vaccination , Gemcitabine
10.
World J Gastroenterol ; 20(39): 14420-9, 2014 Oct 21.
Article in English | MEDLINE | ID: mdl-25339828

ABSTRACT

AIM: To examine whether commensal bacteria are a contributing cause of stress-related mucosal inflammation. METHODS: Human peripheral blood monocyte-derived dendritic cells (MoDCs) were stimulated by commensal bacterial strains, including Escherichia coli, Clostridium clostridioforme, Bacteroides vulgatus (B. vulgatus), Fusobacterium varium (F. varium), and Lactobacillus delbrueckii subsp. bulgaricus. After incubation, corticotropin-releasing factor (CRF) and urocortin 1 (UCN1) mRNA in the cells was examined by real-time reverse transcription polymerase chain reaction. Supernatants from the cells were tested for CRF and UCN1 using an enzyme-linked immunosorbent assay. RESULTS: Both CRF and UCN1 were significantly augmented by B. vulgatus and F. varium at both the mRNA and protein levels. In particular, B. vulgatus stimulated human MoDCs, resulting in extremely high levels of CRF and UCN1. CONCLUSION: Stimulation of MoDCs by B. vulgatus and F. varium may be associated with CRF/UCN1-related intestinal disorders, such as irritable bowel syndrome and inflammatory bowel disease.


Subject(s)
Corticotropin-Releasing Hormone/metabolism , Dendritic Cells/metabolism , Dendritic Cells/microbiology , Intestines/microbiology , Urocortins/metabolism , Adult , Corticotropin-Releasing Hormone/genetics , Dendritic Cells/immunology , Host-Pathogen Interactions , Humans , Male , Middle Aged , Phenotype , RNA, Messenger/metabolism , Symbiosis , Up-Regulation , Urocortins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL